Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
61.7M
-
Shares change
-
+14.9M
-
Total reported value, excl. options
-
$49M
-
Value change
-
+$12.1M
-
Number of buys
-
20
-
Number of sells
-
-11
-
Price
-
$0.79
Significant Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q4 2024
37 filings reported holding UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q4 2024.
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.7M shares
.
Largest 10 shareholders include GREAT POINT PARTNERS LLC (11M shares), Nantahala Capital Management, LLC (10.4M shares), Octagon Capital Advisors LP (10M shares), Vivo Capital, LLC (9.97M shares), Logos Global Management LP (5.08M shares), Walleye Capital LLC (5M shares), SILVERARC CAPITAL MANAGEMENT, LLC (2.49M shares), ACUTA CAPITAL PARTNERS, LLC (2.3M shares), Alyeska Investment Group, L.P. (1.75M shares), and Altium Capital Management LLC (1.47M shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.